Reducing Vaccine Hesitancy for COVID-19
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to reduce vaccine hesitancy among Hispanic parents regarding COVID-19 vaccines for their children. It will compare a digital storytelling approach, where parents watch short videos created by other Hispanic parents about their vaccine experiences, to a standard information sheet from the CDC. The goal is to determine if these personalized stories help increase vaccination rates. Parents who identify as Hispanic, have at least one child under 18 who isn't fully vaccinated against COVID-19, and are willing to share their child's vaccination record via text are suitable candidates for this study. As an unphased study, this trial offers a unique opportunity to contribute to innovative research that could enhance community health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this intervention is safe?
Research has shown that digital storytelling can safely reduce vaccine hesitancy among Hispanic parents. One study found this approach effective and well-received by the community. Participants watched short stories about real vaccine experiences, and no negative effects were reported. This suggests that participants find digital storytelling easy to handle.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to reduce vaccine hesitancy, a crucial barrier to public health. Unlike traditional methods that often rely on static information sheets, this trial employs digital storytelling—a dynamic approach using engaging stories featuring real experiences from Hispanic parents about COVID-19 vaccines. This method aims to resonate on a personal level, potentially making the information more relatable and impactful. By comparing this with standard information sheets, the trial hopes to find out which approach is more effective in changing attitudes and behaviors towards vaccination.
What evidence suggests that this trial's interventions could be effective in reducing vaccine hesitancy for COVID-19?
This trial will compare the effectiveness of a Digital Storytelling Intervention with an Information Control Intervention in reducing vaccine hesitancy. Studies have shown that digital storytelling can effectively reduce vaccine hesitancy. Research suggests that stories resonating with specific communities can address their concerns. For example, one study found that parents who watched digital stories about vaccines were less hesitant to vaccinate their children three months later. These stories correct false information and make facts more relatable, which is important for increasing vaccine acceptance. Overall, digital storytelling shows promise in changing attitudes toward vaccines by making the message more personal and engaging.12467
Who Is on the Research Team?
Alexis Koskan, Ph.D
Principal Investigator
Arizona State University
Sunny W Kim, Ph.D
Principal Investigator
Arizona State University
Are You a Good Fit for This Trial?
This trial is for Hispanic parents or guardians of children under 18 who haven't had their COVID-19 vaccinations up to date. Participants must self-identify as Hispanic, be willing to communicate via text, and provide a photo of their child's immunization record.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete a baseline assessment using the web-based data collection platform before random assignment to control or intervention arm
Intervention
Participants in the intervention group watch digital stories about COVID-19 vaccine experiences among Hispanic parents
Follow-up
Participants are monitored for changes in vaccine hesitancy and vaccination behaviors
What Are the Treatments Tested in This Trial?
Interventions
- Digital Storytelling Intervention
- Information Control Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arizona State University
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator